当前位置:
首页
>
产品中心 >
Tag_antibody >
Hycult Biotech/C5b-9, Rat, mAb 2A1, immuno assay antibody/HM3033-IA/0.5 mg

Hycult Biotech/C5b-9, Rat, mAb 2A1, immuno assay antibody/HM3033-IA/0.5 mg
商品编号:
HM3033-IA
品牌:
hycultbiotech
市场价:
¥21740.00
美元价:
13044.00
产品分类:
标签抗体
公司分类:
Tag_antibody
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Description:C5b-9,Rat,mAb2A1,immunoassayantibody
Themonoclonalantibody2A1recognizesratC5b-9.TheantibodywasshowntocompetewithantibodiestohumanC9foritsbindingsiteontheC5b-9complex,indicatingthatthereactiveepitopeislocatedontheC9molecule.C5b-9membraneattackcomplexesareassembledfromfiveprecursormoleculesintheserum.ProteolyticcleavageofC5byC5convertasegeneratesC5bwhichinitiatesassemblyoftheC5b-9complex.ThelaststepofC5b-9complexformationinvolvespolymerizationofC9whichaccompaniesinsertionofthecomplexintothecellmembrane.DuringformationofC5b-8andC9polymerization,neoantigensaregeneratedwhichareuniquetotheC5b-9complexandarenotpresentonanyoftheindividualnativecomplexcomponents.ThecomplementregulatoryproteinsCD59andcomplementS-proteincanbothpreventC5b-9insertionintothecellmembrane.TheformedSC5b-9complexisunabletoattachtocellsandiscytolyticallyinactive.C5b-9isinvolvedintheprogressionofchronicproteinuricrenaldiseasebymediatingcontinuoustubulointerstitialdamage.EarlytubulointerstitialinjuryintheremnantkidneycanbeimprovedwhenC5b-9complexformingisabrogated.
Themonoclonalantibody2A1wasraisedagainstaratC5b-9neoantigen.Monoclonalantibody2A1canbeusedasacoatingantibodytodetectC5b-9inplasmaandurinesamples.
Themonoclonalantibody2A1wasraisedagainstaratC5b-9neoantigen.Monoclonalantibody2A1canbeusedasacoatingantibodytodetectC5b-9inplasmaandurinesamples.
Specifications:
Catalognumber | HM3033-IA |
---|---|
Producttype | Monoclonalantibodies |
Quantity | 0.5mg |
Formulation | 0.5mgof0.2μmfilteredproteinGpurifiedantibodysolutioninPBS(exactconcentrationisindicatedonthelabel). |
Application | Flowcytometry,Frozensections,Immunoassays,Immunofluorescence,Paraffinsections,Westernblot |
ApplicationNotes | IA:plateswerecoatedwith30μg/mlin50mMcarbonatebuffer,pH10.6for16hat4°C.(Ref.1) W:Anon-reducedsampletreatmentandSDS-Pagewasused.Thebandsizeis>200kDa(Ref.1). IHC-P:TissuesectionsfixedinformalinwerepretreatedwithproteasetypeXXIVfor10minutesat37⁰Cbeforeincubation(Ref.6). IHC-F:Tissuesectionswerefixedinacetonefor10minutesatroomtemperaturebeforeincubation(Ref.3). |
Use | Dilutionstobeuseddependondetectionsystemapplied.Itisrecommendedthatuserstestthereagentanddeterminetheirownoptimaldilutions.Thetypicalstartingworkingdilutionis1:50. |
Immunogen | RatC5b-9 |
Isotype | MouseIgG1 |
Species | Rat |
Alias | Membraneattackcomplex,MAC,TCC,TerminalComplementComplex |
PositiveControl | Glomeruliofratstreatedwithanti-Thy-1.1antibodies |
References | 1.Schulze,Metal.IncreasedurinaryexcretionofC5b-9distinguishespassiveHeymannnephritisintherat.KidneyInt.1989,35:60 2.Brandt,Jetal.Roleofthecomplementmembraneattackcomplex(C5b-9)inmediatingexperimentalmesangioproliferativeglomerulonephritis.KidneyInt.1996,49:335 3.Sato,Tetal.Theterminalsequenceofcomplementplaysanessentialroleinantibody-mediatedrenalcellapoptosis.JAmSocNephrol1999,10:1242 4.Duijvestijn,A.Complementactivationbyanti-endothelialcellantibodiesinMHC-mismatchedandMHC-matchedheartallograftrejection:anti-MHC,butnotantinon-MHCalloantibodiesareeffectiveincomplementactivation.Transpl.Int.2000,13:363 5.Yamada,Ketal.Clusterinisup-regulatedinglomerularmesangialcellsincomplement-mediatedinjury.KidneyIntern2001.59:137 6.NangakuMetal.C6mediateschronicprogressionoftubulointerstitialdamageinratswithremnantkidneysJ.Am.Soc.Nephrol.2002,13:928 7.RanganGKetal.C5b-9regulatesperitubularmyofibroblastaccumulationinexperimentalfocalsegmentalglomerulosclerosis.KidneyInt2004,66:1838 8.Ostendorf,Tetal.AntagonismofPDGF-DbyhumanantibodyCR002preventsrenalscarringinexperimentalglomerulonephritis.JAmSocNephrol2006,17:1054 9.Pol,P;Pathogenicroleofcomplementinrenalischemia/reperfusioninjury.Thesis2013 10.Kotimaa,Jetal;FunctionalassessmentofratcomplementpathwayactivitiesandquantificationofsolubleC5b-9inanexperimentalmodelofrenalischemia/reperfusioninjury.JImmMeth2014,412:14 |
StorageandstABIlity | Productshouldbestoredat4 °C.Underrecommendedstorageconditions,productisstableforoneyear. |
Precautions | Forresearchuseonly.Notforuseinoronhumansoranimalsorfordiagnostics.Itistheresponsibilityoftheusertocomplywithalllocal/stateandfederalrulesintheuseofthisproduct.HycultBiotechisnotresponsIBLeforanypatentinfringementsthatmightresultfromtheuseorderivationofthisproduct. |
Disease | Infectiousdiseases,Nephrology |
品牌介绍
荷兰HyCult Biotechnology(HBT)位于荷兰乌登,从1994开始制造检测抗体和蛋白质,主要侧重与病理学诊断有关的全套产品研发,既有纯化的重组蛋白和多肽,也有单抗和多抗,是世界一流的先天免疫领域的研究试剂制造商。
联络我们